UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): |
(Exact name of Registrant as Specified in Its Charter)
(State or Other Jurisdiction |
(Commission File Number) |
(IRS Employer |
||
|
|
|
|
|
|
||||
|
||||
(Address of Principal Executive Offices) |
|
(Zip Code) |
||
Registrant’s Telephone Number, Including Area Code: |
|
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
|
|
Trading |
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers.
On May 22, 2024, Hans E. Bishop notified the board of directors (the “Board”) of Agilent Technologies, Inc. (the “Company”) of his intention to step down as a member of the Company’s Board, effective as of May 23, 2024. Mr. Bishop is a member of the Compensation Committee and Nominating/Corporate Governance Committee of the Board. Mr. Bishop has served as a member of the Board since 2017. Mr. Bishop’s departure is not the result of any disagreement with the Company regarding its operations, policies or practices.
In connection with Mr. Bishop’s departure, the size of the Board has been reduced from eleven (11) to ten (10) directors, effective as of May 23, 2024.
The Company issued a press release on May 23, 2024 announcing Mr. Bishop’s departure from the Company’s Board. A copy of the press release is attached as Exhibit 99.1 to this report and incorporated by reference herein.
Item 9.01 - Financial Statements and Exhibits.
(d) Exhibits
The following is furnished as an exhibit to this report and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended:
Exhibit No. |
|
Description |
|
|
|
|
Press release dated May 23, 2024 |
||||
104 |
|
Cover Page Interactive Data File (embedded within the Inline XBRL document |
|||
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
|
AGILENT TECHNOLOGIES, INC. |
|
|
|
|
Date: |
May 23, 2024 |
By: |
/s/ P. Diana Chiu |
|
|
Name: |
P. Diana Chiu |
|
|
Title: |
Vice President, Interim General Counsel & Secretary |
Exhibit 99.1
Agilent Announces Hans E. Bishop Has Stepped Down from Board of Directors
SANTA CLARA, Calif. May 23, 2024 – Agilent Technologies Inc. (NYSE: A) today announced that Hans E. Bishop, president and co-founder of Altos Labs, has stepped down from serving on Agilent’s board of directors.
Bishop joined Agilent’s board in July 2017, after holding a range of leadership positions in the pharmaceutical industry. “Hans’ extensive life science industry leadership and insight have been of great value to the board. We are grateful for his contributions over the past seven years and wish him all the best,” said Koh Boon Hwee, chairman of the board.
Bishop will continue advising Agilent and CEO Padraig McDonnell in an informal capacity. “While I regret having to step away from the board due to other commitments, I am excited about and confident in Agilent’s future under Padraig’s leadership,” said Bishop. “Agilent’s role in enhancing the efficiency and innovation of pharma and biotech companies has become even more essential in this era of rich scientific discovery.”
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent’s full range of solutions includes instruments, software, services, and expertise that provide trusted answers to our customers' most challenging questions. The company generated revenue of $6.83 billion in fiscal 2023 and employs approximately 18,000 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn and Facebook.
Media Contact: Tom Beermann +1 408-386-5892 tom.beermann@agilent.com |
Investor Contact: Parmeet Ahuja +1 408-345-8948 parmeet_ahuja@agilent.com |
Document And Entity Information |
May 22, 2024 |
|---|---|
| Cover [Abstract] | |
| Document Type | 8-K |
| Amendment Flag | false |
| Document Period End Date | May 22, 2024 |
| Entity Registrant Name | AGILENT TECHNOLOGIES, INC. |
| Entity Central Index Key | 0001090872 |
| Entity Emerging Growth Company | false |
| Entity File Number | 001-15405 |
| Entity Incorporation, State or Country Code | DE |
| Entity Tax Identification Number | 77-0518772 |
| Entity Address, Address Line One | 5301 Stevens Creek Boulevard |
| Entity Address, City or Town | Santa Clara |
| Entity Address, State or Province | CA |
| Entity Address, Postal Zip Code | 95051 |
| City Area Code | 800 |
| Local Phone Number | 227-9770 |
| Written Communications | false |
| Soliciting Material | false |
| Pre-commencement Tender Offer | false |
| Pre-commencement Issuer Tender Offer | false |
| Title of 12(b) Security | Common Stock, $0.01 par value |
| Trading Symbol | A |
| Security Exchange Name | NYSE |
%^@2O&+(=/EB>N$_NG_A.
M\SQ-LPRKZ'8;9;#%ZI9E\!>/AG$##RP/9'I;K?%NXQ/R^AQ@/7UM0K"=XI.(
M[12O-2#QNH%'GL>[C>4!#ZP+V.Q _G@>F*FX3YI"5S%NV G&D3S'$)C%^(QF
M&5*=##[Q_F"G)$WS/(X %F>0IA@"IQ%', ; 4/2='@//GL?)=-[*CG_5U/\
M!%!+ P04 " 7C[=8EXJ[', 3 @ "P %]R96QS+RYR96QSG9*Y
M;L,P#$!_Q=">, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI
M0.TXI+:+J1C]$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N&6:W
MO606IW.D5XA /MU@ZJJ+G0 $ #P" / "
M 6(0 !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4 " 7C[=8)!Z;HJT #X
M 0 &@ @ '/$0 >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E
M;'-02P$"% ,4 " 7C[=899!YDAD! #/ P $P @ &T
L$@ 6T-O;G1E;G1?5'EP97-=+GAM;%!+!08 "0 ) #X" #^$P !
end